The chemical substance known as 2-[1-(4-Methoxy-2-methylphenyl)-6-(trifluoromethoxy)-2,3-dihydro-1H-pyrrolo[3,2-c]quinolin-4-ylamino]ethanol, with the CAS number 220853-65-6, is a complex organic compound characterized by its unique structural features. It contains a pyrroloquinoline core, which is fused with various functional groups, including a methoxy group and a trifluoromethoxy group, contributing to its potential biological activity. The presence of an amino group linked to an ethanol moiety suggests that this compound may exhibit properties relevant to medicinal chemistry, possibly acting as a pharmacophore in drug development. Its molecular structure indicates potential interactions with biological targets, making it of interest in pharmaceutical research. Additionally, the trifluoromethoxy group may enhance lipophilicity and metabolic stability, which are important factors in drug design. Overall, this compound's intricate architecture and functional groups position it as a candidate for further investigation in therapeutic applications.

2-[1-(4-Methoxy-2-methylphenyl)-6-(trifluoromethoxy)-2,3-dihydro-1H-pyrrolo[3,2-c]quinolin-4-ylamino]ethanol

220853-65-6: The chemical substance known as 2-[1-(4-Methoxy-2-methylphenyl)-6-(trifluoromethoxy)-2,3-dihydro-1H-pyrrolo[3,2-c]quinolin-4-ylamino]ethanol, with the CAS number 220853-65-6, is a complex organic compound characterized by its unique structural features. It contains a pyrroloquinoline core, which is fused with various functional groups, including a methoxy group and a trifluoromethoxy group, contributing to its potential biological activity. The presence of an amino group linked to an ethanol moiety suggests that this compound may exhibit properties relevant to medicinal chemistry, possibly acting as a pharmacophore in drug development. Its molecular structure indicates potential interactions with biological targets, making it of interest in pharmaceutical research. Additionally, the trifluoromethoxy group may enhance lipophilicity and metabolic stability, which are important factors in drug design. Overall, this compound's intricate architecture and functional groups position it as a candidate for further investigation in therapeutic applications.

<p>KR 60436 is an inhibitor of potassium hydrogen ATPase.</p>

CAS 220853-65-6

2-[1-(4-Methoxy-2-methylphenyl)-6-(trifluoromethoxy)-2,3-dihydro-1H-pyrrolo[3,2-c]quinolin-4-ylamino]ethanol

KR 60436

Ref: TM-T69802